Shanghai Pharmaceuticals Holding Co (SHSE:601607) Construction In Progress: ¥2,082 Mil (As of Mar. 2026)

What is Shanghai Pharmaceuticals Holding Co Construction In Progress?

Shanghai Pharmaceuticals Holding Co SHSE:601607 -1.40% 73 Construction In Progress is ¥2,082 Mil as of Mar. 2026. GuruFocus rates SHSE:601607 with a GF Score™ of 73/100 and a GF Value™ of ¥19.97 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Shanghai Pharmaceuticals Holding Co's quarterly construction in progress declined from Sep. 2025 (¥2,476 Mil) to Dec. 2025 (¥1,994 Mil) but then increased from Dec. 2025 (¥1,994 Mil) to Mar. 2026 (¥2,082 Mil).

Shanghai Pharmaceuticals Holding Co's annual construction in progress declined from Dec. 2023 (¥3,570 Mil) to Dec. 2024 (¥2,149 Mil) and declined from Dec. 2024 (¥2,149 Mil) to Dec. 2025 (¥1,994 Mil).

Shanghai Pharmaceuticals Holding Co Construction In Progress Historical Data

* Premium members only.

The historical data trend for Shanghai Pharmaceuticals Holding Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Pharmaceuticals Holding Co Construction In Progress Chart

Shanghai Pharmaceuticals Holding Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Construction In Progress

Get a 7-Day Free Trial

2,914.13

2,777.36

3,569.63

2,148.65

1,994.09

Shanghai Pharmaceuticals Holding Co Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Construction In Progress	Get a 7-Day Free Trial															2,304.08	2,382.16	2,475.54	1,994.09	2,081.78

73GF Score

Shanghai Pharmaceuticals Holding Co Ltd SHSE:601607

Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Shanghai Pharmaceuticals Holding Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Frequently Asked Questions Learn more about Construction In Progress →

What does a Construction In Progress of ¥2,082 Mil mean?

Shanghai Pharmaceuticals Holding Co (SHSE:601607) has a Construction In Progress of ¥2,082 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors.

Is Shanghai Pharmaceuticals Holding Co's Construction In Progress too high?

Shanghai Pharmaceuticals Holding Co's current Construction In Progress is ¥2,082 Mil. Overall, Shanghai Pharmaceuticals Holding Co has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Shanghai Pharmaceuticals Holding Co's Construction In Progress compare to MCK and CAH?

Shanghai Pharmaceuticals Holding Co's Construction In Progress of ¥2,082 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Construction In Progress for a Medical Distribution company?

A good Construction In Progress depends on the Medical Distribution industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Construction In Progress mean?

A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors. Shanghai Pharmaceuticals Holding Co's current Construction In Progress is ¥2,082 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Shanghai Pharmaceuticals Holding Co stock overvalued right now?

Based on GuruFocus' analysis, Shanghai Pharmaceuticals Holding Co (SHSE:601607) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥19.97, compared to a current price of ¥16.22 — trading 18.8% below its estimated fair value. The current Construction In Progress is ¥2,082 Mil. Shanghai Pharmaceuticals Holding Co's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Construction In Progress calculated?

Construction In Progress is calculated from a company's financial statements. For Shanghai Pharmaceuticals Holding Co (SHSE:601607), the current Construction In Progress is ¥2,082 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Pharmaceuticals Holding Co (SHSE:601607) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Pharmaceuticals Holding Co stock appears to be undervalued. The current stock price of ¥16.22 is trading 18.8% below its estimated GF Value™ of ¥19.97. GuruFocus considers Shanghai Pharmaceuticals Holding Co to be Modestly Undervalued.

Key valuation signals for SHSE:601607:

Construction In Progress: ¥2,082 Mil
GF Value™: ¥19.97 vs. price of ¥16.22 (18.8% below fair value)
GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the SHSE:601607 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Pharmaceuticals Holding Co Business Description

Industry Healthcare Medical Distribution

Comparable Companies SHSE:600332 SHSE:600998 SHSE:600511 SHSE:600739 SHSE:600056 SZSE:000028 SZSE:301015 SZSE:000950 SZSE:301584 SHSE:603368 MCK CAH COR ASX:SIG HSIC HKSE:01099 XSWX:GALE TSE:7459 OSTO:ASKER MIL:AMP

Other Exchanges 02607:Hong Kong S1R:Germany

Address No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020

Website https://www.sphchina.com

Shanghai Pharmaceuticals Holding Co Ltd is engaged in the pharmaceutical drug development and distribution business. The Group's reportable segments are: Production, Distribution, Retail, and Other. The majority of its revenue comes from the Distribution segment, which is mainly engaged in distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services for pharmaceutical manufacturers and dispensers. The Retail segment operates a network of retail pharmacy stores, and the Production segment is mainly engaged in research and development, production, and sales of a broad range of pharmaceutical and healthcare products. Geographically, the Group mainly operates in the People's Republic of China (PRC).

73GF Score

Get the complete analysis for SHSE:601607

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥16.22

Price

¥19.97

GF Value

View SHSE:601607 Analysis

See Construction In Progress data for all stocks →